Epidemiology of viral hepatitis and HIV co-infection

2^nd international conference virology and infectious disease

Date: September 3-4, 2019

Venue: London, UK

URL: https://bit.ly/2NWKh1M

Epidemiology of viral hepatitis and HIV co-infection

Worldwide, viral hepatitis virus (HBV) accounts for Associate in Nursing estimated 370 million chronic infections, viral hepatitis virus (HCV) for Associate in nursing estimated 130 million, Associate in Nursing HIV for a calculable forty million. 

In HIV-infected persons, associate degree calculable 2–4 million have chronic HBV co-infection and 4–5 million have HCV co-infection. HBV, HCV and HIV share common routes of transmission, but they take issue in their prevalence by geographic region and also the efficiency by that sure kind of exposures transmits them. 

Among HIV-positive persons studied from Western Europe and the USA, chronic HBV infection has been found in 6–14% overall, including 4–6% of heterosexuals, 9–17% of men WHO be intimate with men (MSM), and 7–10% of injection drug users. HCV infection has been found in 25–30% of HIV-positive persons overall; 72–95% of injection drug users, 1–12% of MSM and 9–27% of heterosexuals. 

The characteristics of HIV infected persons disagree in keeping with the co-infecting infectious disease virus, their epidemiologic patterns may change over time, and surveillance systems square measure needed to monitor their infection patterns so as to ensure that bar measures square measure targeted appropriately.

To know more about virology and infectious disease, attend an event on Viral Epidemiology at Virology conference

Contact details:
Clara Charlotte
Program Manger | virology 2019
Email: virology@microbioconferences.com
Phone: +44 20 3769 1755